Nanoformed High-Concentration Biologics Formulation for Subcutaneous Delivery Results to be Presented by Takeda at DDF Summit
Press Release Nanoform Finland Plc May 7, 2024 09.10 EEST…
Disclosure of Major Holdings under Law 163/2024
Company Release Nanoform Finland Plc April 26, 2024 11.00 Finnish…
New shares of Nanoform registered with the trade register
Company Release Nanoform Finland Plc April 25, 2024 17.00 Finnish…
Nanoform successfully completes new share issue raising EUR 15.4 million to invest in commercialization of nanoparticle enabled formulations for next generation medicines
Inside information Nanoform Finland Plc April 24, 2024 22.50 Finnish…
Nanoform announces its intention to carry out a new share issue of approximately 7 million new shares to invest in commercialization of nanoparticle enabled formulations for next generation medicines
Inside information Nanoform Finland Plc April 24, 2024 18.31 Finnish…
Resolutions of the Constitutive Meeting of the Board of Directors of Nanoform Finland Plc
Company release Nanoform Finland Plc April 16, 2024 13.50 Finnish…
Resolutions of Nanoform Finland Plc’s Annual General Meeting on April 16, 2024
Company release Nanoform Finland Plc April 16, 2024 13.40 Finnish…
14th American DDF Summit,San Diego, US
Nanoform is proud to be sponsoring the Global Drug Delivery…